Palvella Therapeutics names pediatric dermatologist James Treat chief medical officer - PVLA News | RalliesPalvella Therapeutics names pediatric dermatologist James Treat chief medical officer
P
PVLA• Palvella appoints James Treat as chief medical officer
- Palvella Therapeutics appointed James R. Treat as chief medical officer, effective Dec. 21, 2026.
- Treat most recently served as a pediatric dermatologist at Children’s Hospital of Philadelphia.
- He was associate program director of CHOP’s Pediatric Dermatology Fellowship Program, following more than 12 years as program director.
- Treat has been a QTORIN rapamycin trial investigator, including as a site investigator for the Phase 3 SELVA study.
